Do patients with a higher body mass index have a greater risk of advanced-stage renal cell carcinoma?

Urology

Volumn 62, Issue 3, 2003, Pages 437-441

  Schips, Luigi ^a   Zigeuner, Richard ^b   Lipsky, Katja ^b   Quehenberger, Franz ^b   Salfellner, Michael ^b   Winkler, Susanne ^b   Pummer, Karl ^b   Hubmer, Gerhart ^b  

^a UNIVERSITY HOSPITAL GRAZ   (Austria)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HEMOGLOBIN; LACTATE DEHYDROGENASE; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; ADVANCED CANCER; AGE; AGED; ARTICLE; BASAL METABOLIC RATE; BODY MASS; CANCER PATIENT; CANCER STAGING; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; GENDER; HUMAN; KIDNEY CARCINOMA; KIDNEY SURGERY; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; PARAMETER; PRIORITY JOURNAL; RISK FACTOR; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SYMPTOM; SYMPTOMATOLOGY; TRIACYLGLYCEROL BLOOD LEVEL; TUMOR DIAGNOSIS; TUMOR VOLUME;

EID: 0042233876     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(03)00380-7     Document Type: Article

References (30)

1. Chow W.H., Devesa S.S., Warren J.L., et al. Rising incidence of renal cell carcinoma in the United States. JAMA. 281:1999;1628-1631.
2. Wolk A., Gridley G., Niwa S., et al. International renal cell cancer study. VII. Role of diet. Int J Cancer. 65:1996;67-73.
3. Wolk A., Lindblad P., Adami H.O. Nutrition and renal cell cancer. Cancer Causes Control. 7:1996;5-18.
4. Chow W.H., Gridley G., McLaughlin J.K., et al. Protein intake and risk of renal cell cancer. J Natl Cancer Inst. 86:1994;1131-1139.
5. Moyad M.A. Obesity, interrelated mechanisms, and exposures and kidney cancer. Semin Urol Oncol. 19:2001;270-279.
6. Chow W.H., Gridley G., Fraumeni J.F., et al. Obesity, hypertension and the risk of kidney cancer in men. N Engl J Med. 343:2000;1305-1311.
7. Schlehofer B., Pommer W., Mellengaard A., et al. International renal-cell-cancer study. VI. The role of medical family history. Int J Cancer. 66:1996;723-726.
8. Asal N.R., Risser D.R., Kadamani S., et al. Risk factors in renal cell carcinoma I. Methodology, demographics, tobacco, beverage use, and obesity . Cancer Detect Prev. 11:1988;359-377.
9. Yu M.C., Mack T.M., Hanisch R., et al. Cigarette smoking, obesity diuretic use, and coffee consumption as risk factors for renal cell cancer. J Natl Cancer Inst. 77:1986;351-356.
10. Oh W.K., Manola J., Renshaw A.A., et al. Smoking and alcohol use may be risk factors for poorer outcome in patients with clear cell renal cell carcinoma. Urology. 55:2000;31-35.
11. Tavani A., La Vecchia C. Epidemiology of renal cell carcinoma. J Nephrol. 10:1997;93-106.
12. Chow W.H., McLaughlin J.K., Mandel J.S., et al. Obesity and risk of renal cell cancer. Cancer Epidemiol Biomarkers Prev. 5:1996;17-21.
13. Mellemgaard A., Moller H., Olsen J.H., et al. Increased risk of renal cell carcinoma among obese women. J Natl Cancer Inst. 83:1991;1581-1582.
14. Bergstrom A., Hsieh C.C., Lindblad P., et al. Obesity and renal cell cancer - a quantitative review. Br J Cancer. 85:2001;984-990.
15. Shapiro J.A., Williams M.A., Weiss N.S. Body mass index and risk of renal cell carcinoma. Epidemiology. 10:1999;188-191.
16. Cui Y., Whiteman M.K., Flaws J.A., et al. Body mass and stage of breast cancer at diagnosis. Int J Cancer. 98:2002;279-283.
17. Pummer K., Stettner H., Trummer H., et al. Body mass index is an independent predictor for organ confined prostate cancer. (abstract) J Urol. 163:(suppl):2000;183.
18. Yu M.L., Asal N.R., Geyer J.R. Later recurrence and longer survival among obese patients with renal cell carcinoma. Cancer. 68:1991;1648-1655.
19. Tsui K.H., Shvarts O., Smith R.B., et al. Renal cell carcinoma prognostic significance of incidentally detected tumors . J Urol. 163:2000;426-430.
20. Luciani L.G., Cestari R., Tallarigo C. Incidental renal cell carcinoma - age and stage characterisation and clinical implications study of 1092 patients (1982-1997) . Urology. 56:2000;58-62.
21. Chisholm G.D. Nephrogenic ridge tumors and their syndromes. Ann NY Acad Sci. 230:1974;403-423.
22. Knekt P., Reunanen A., Aromaa A., et al. Serum cholesterol and risk of cancer in a cohort of 39,000 men and women. J Clin Epidemiol. 41:1988;519-530.
23. Eichholzer M., Stahelin H.B., Gutzwiller F., et al. Association of low plasma cholesterol with mortality for cancer at various sites in men 17-y follow-up of the prospective Basel study . Am J Clin Nutr. 71:2000;569-574.
24. Rudling M., Collins V.P. Low density lipoprotein receptor and 3-hydroxy-3-methylglutaryl coenzyme A reductase mRNA levels are coordinately reduced in human renal cell carcinoma. Biochem Biophys Acta. 1299:1996;75-79.
25. Henriksson P., Eriksson M., Ericsson S., et al. Hypocholesterolaemia and increased elimination of low-density lipoproteins in metastatic cancer of the prostate. Lancet. 2:1989;1178-1180.
26. Wannamethee G., Shaper A.G., Whincup P.H., et al. Low serum total cholesterol concentrations and mortality in middle aged British men. BMJ. 311:1995;409-413.
27. Lau W.K., Cheville J.C., Blute M.L., et al. Prognostic features of pathologic stage T1 renal cell carcinoma after radical nephrectomy. Urology. 59:2002;532-537.
28. Yayciogly O., Roberts W.W., Chan T., et al. Prognostic assessment of nonmetastatic renal cell carcinoma a clinically based model . Urology. 58:2001;141-145.
29. Roosen J.U., Engel U., Jensen R.H., et al. Renal cell carcinoma prognostic factors . Br J Urol. 74:1994;160-164.
30. Citterio G., Bertuzzi A., Tresoldi M., et al. Prognostic factors for survival in metastatic renal cell carcinoma retrospective analysis from 109 consecutive patients . Eur Urol. 31:1997;286-291.